eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2011
vol. 49
 
Share:
Share:
abstract:

Original article
Presence of L-kynurenine aminotransferase III in retinal ganglion cells and corpora amylacea in the human retina and optic nerve

Robert Rejdak
,
Carmen Rummelt
,
Eberhart Zrenner
,
Pawel Grieb
,
Konrad Rejdak
,
Etsuo Okuno
,
Sebastian Thaler
,
Katarzyna Nowomiejska
,
Friedrich Kruse
,
Waldemar Turski
,
Anselm GM Junemann

Folia Neuropathol 2011; 49 (2): 132-137
Online publish date: 2011/07/04
View full text Get citation
 
Background: Corpora amylacea (CAm) are a hallmark of aging and neurodegeneration. The presence of kynurenine aminotransferases I and II (KAT I and II) in CAm in the human retina and optic nerve has been already shown. The present study aimed to examine kynurenine aminotransferase III (KAT III) immunoreactivity in CAm in the human retina and optic nerve.

Material and methods: Polyclonal antibody against KAT III was used on sections of human eyes enucleated due to malignant uveal melanoma. PAS-stained sections of CAm were compared with KAT III stained ones.

Results: KAT III immunoreactivity was observed in CAm in the retina, prelaminar, laminar and retrolaminar region of the optic nerve with similar location to PAS-stained sections. The most intense staining was observed in the retrolaminar part of the optic nerve. KAT III immunoreactivity was also present in the cytoplasm of retinal ganglion cells.

Conclusions: Expression of KAT III in CAm in the human retina and optic nerve indicates that this enzyme may be relevant in mechanisms of neurodegeneration leading to CAm formation.
keywords:

corpora amylacea, degeneration, KAT III, kynurenic acid, retina, immunohistochemistry

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.